Aktuellt
SENASTE
We cut our forecasts ahead of the Q1 report on lower future trauma sales for Zimmer, based on recent momentum. Bactiguard has successfully expanded its addressable market in recent years and has invested in opex to generate strong sales. We want to see better momentum in BIP product sales and stronger uptake of newly initiated partnerships in the future, something we think should flow from the investments.
LÄS MER
